骶神经调节在女性糖尿病性膀胱功能障碍治疗中的应用

张倩; 李普; 江杰; 唐敏; 孟小鑫

doi:10.13201/j.issn.1001-1420.2019.06.002

骶神经调节在女性糖尿病性膀胱功能障碍治疗中的应用

- 南京医科大学第一附属医院泌尿外科(南京, 210029)

详细信息

通讯作者: 孟小鑫,E-mail:mengxiaoxin@126.com

中图分类号: R587.2

收稿日期: 2019-03-29

Applications of SNM therapy in treating female diabetic bladder dysfunction

- Department of Urology, First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China

More Information

Corresponding author: MENG Xiaoxin, E-mail: mengxiaoxin@126.com

Received Date: 29 March 2019

摘要

摘要: 目的:总结骶神经调节(SNM)治疗女性糖尿病性膀胱功能障碍(DBD)患者的初步经验。方法:回顾性分析2017年5月~2018年8月我院采用SNM治疗的10例女性DBD患者的临床资料,年龄43~72岁,平均51岁,糖尿病病程2~23年,膀胱功能障碍病程0.5~8年,比较治疗前、Ⅰ期测试阶段及Ⅱ期永久刺激器植入后随访中相关症状的改善程度,观察该疗法的有效性及安全性,并初步总结相关经验。结果:10例患者均在局麻下接受了SNMⅠ期电极植入,4例因测试效果不佳,于局麻下取出测试电极。6例经测试后行Ⅱ期永久刺激器植入,Ⅰ期至Ⅱ期转换率为60%(6/10)。接受Ⅱ期刺激器永久植入患者在随访截止时与治疗前相比,日排尿次数[(11.2±9.6)次vs.(18.3±9.4)次,P=0.02]、每次排尿量[(181.3±61.5) ml vs.(104.5±55.3) ml,P＜0.01]、生活质量评分[(3.5±1.5)分vs.(6.2±1.3)分,P＜0.01]、残余尿量[(66.7±57.9) ml vs.(188.6±63.4) ml,P＜0.01]、排尿困难评分[(3.9±1.4)分vs.(8.2±1.7)分,P＜0.01]均显著改善。围手术期未见明显并发症发生,1例患者随访中出现手术侧臀部及下肢疼痛不适,通过程控改变电刺激模式后好转。5例在Ⅱ期植入术后症状持续缓解,1例出现症状反复,症状缓解不明显,予以保留刺激器并结合间断清洁自我导尿。结论:对于女性DBD患者,SNM是一种安全、有效的微创治疗方式。选择合适的患者、更精细的手术操作及适当延长测试的时间,可以提高转换率,改善患者疗效。
- 糖尿病性膀胱功能障碍 /
- 骶神经调节 /
- 女性
Abstract: Objective: To investigate the infect of Sacral neuromodulation therapy upon the patient of diabetic bladder dysfunction. Method: Between May 2017 to August 2018, 10 female patients with diabetic bladder dysfunction were treated with SNM therapy in the First Affiliated Hospital of Nanjing Medical University. The symptom improvement of pretherapy, phase I (testing phase), phase II (post permanent stimulator implantation) were compared and the safety of SNM in such patients was observed. Result: 10 patients received phase I electrode stimulator implantation under local anaesthesia, and electrode stiumlators were removed in 4 cases due to unsatisfactory effect. The other 6 cases undergo a permanent SNM procedure, the conversion rate was 60% (6/10). Number of urinations per day [(11.2±9.6) times vs. (18.3±9.4) times, P=0.02], urinary volume per time [(181.3±61.5) ml vs. (104.5±55.3) ml, P＜0.01], quality of life [(3.5±1.5) vs. (6.2±1.3), P＜0.01], residual volume [(66.7±57.9) ml vs. (188.6±63.4) ml, P＜0.01], dysuria score [(3.9±1.4) vs (8.2±1.7), P＜0.01] were significant improved after permanent SNM procedure compared with pretherapy. No obvious complications occurred during perioperative period. pain and discomfort in surgical location was observed in one case and was relieved by modified electrical stimulus pattern. 5 cases received long period of relief after permanent SNM procedure. Recurrence of symptoms was observed in one patient, and intermittent self-catheterization was introduced to this patient with the stimulator reserved.Conclusion: SNM is a safety, effective and minimally invasive manner for femal diabetic bladder dysfunction patients. Appropriate patient selection, expertly surgical operation and appropriately prolonged testing can significantly improve the conversion rate and efficacy.
- diabetic bladder dysfunction /
- sacral neuromodulation /
- female

HTML全文

参考文献(17)

[1]	Yang W, Lu J, Weng J, et al.Prevalence of diabetes among men and women in China[J].N Engl J Med, 2010, 362 (12):1090-1101.
[2]	Frimodt Moller C.Diabetic cystopathy:epidemiology and related disorders[J].Ann Intern Med, 1980, 92 (2 Pt 2):318-321.
[3]	Steele S S.Sacral nerve stimulation:50 years in the making[J].Can Urol Assoc J, 2012, 6 (4):231-232.
[4]	陈国庆, 廖利民.骶神经调节术治疗下尿路功能障碍:单中心14年经验总结[J].微创泌尿外科杂志, 2016, 5 (5):263-267.
[5]	骶神经调控术临床应用专家共识编写组.骶神经调控术临床应用中国专家共识再版[J].中华泌尿外科杂志, 2018, 39 (11):801-804.
[6]	张鹏, 张建忠, 吴栗洋, 等.骶神经调节治疗非神经源性、非机械梗阻性排尿困难的临床研究[J].中华泌尿外科杂志, 2017, 38 (11):806-810.
[7]	Papaefstathiou E, Moysidis K, Sarafis P, et al.The impact of Diabetes Mellitus on Lower urinary tract symptoms (LUTS) in both male and female patients[J].Diabetes Metab Syndr, 2019, 13 (1):454-457.
[8]	Lee S, Rose'Meyer R, McDermott C, et al.Diabetes-induced alterations in urothelium function:Enhanced ATP release and nerve-evoked contractions in the streptozotocin rat bladder[J].Clin Exp Pharmacol Physiol, 2018, 45 (11):1161-1169.
[9]	刘亚东, 卫中庆, 张思聪, 等.糖尿病膀胱的研究进展[J].临床泌尿外科杂志, 2018, 33 (7):582-585.
[10]	王东文, 双卫兵.糖尿病膀胱逼尿肌的病理改变及机制[J].临床泌尿外科杂志, 2005, 20 (11):649-651.
[11]	Liu R T, Chung M S, Lee W C, et al.Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes[J].Urology, 2011, 78 (5):1040-1045.
[12]	Tahseen S.Role of sacral neuromodulation in modern urogynaecology practice:a review of recent literature[J].Int Urogynecol J, 2018, 29 (8):1081-1091.
[13]	Tuite G F, Storrs B B, Homsy Y L, et al.Attempted bladder reinnervation and creation of a scratch reflex for bladder emptying through a somatic-to-autonomic intradural anastomosis[J].J Neurosurg Pediatr, 2013, 12 (1):80-86.
[14]	Jonas U, Fowler C J, Chancellor M B, et al.Efficacy of sacral nerve stimulation for urinary retention:results 18 months after implantation[J].J Urol, 2001, 165 (1):15-19.
[15]	Mehmood S, Altaweel W M.Long-term outcome of sacral neuromodulation in patients with idiopathic nonobstructive urinary retention:Single-center experience[J].Urol Ann, 2017, 9 (3):244-248.
[16]	Kessler T M, La Framboise D, Trelle S, et al.Sacral neuromodulation for neurogenic lower urinary tract dysfunction:systematic review and meta-analysis[J].Eur Urol, 2010, 58 (6):865-874.
[17]	Daniels D H, Powell C R, Braasch M R, et al.Sacral neuromodulation in diabetic patients:success and complications in the treatment of voiding dysfunction[J].Neurourol Urodyn, 2010, 29 (4):578-581.